Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
NCT01078324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2016-08-19
Summary
The purpose of this study is to study the demographic,laboratory,endoscopic, and outcomes of ischemic colitis patient presented with severe lower gastrointestinal bleeding compared to other diagnoses.
Conditions
- Colitis, Ischemic
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Dennis M Jensen, M.D. · University of California, Los Angeles
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-12-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- United States
Study Locations
More Related Trials
-
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410 ·Status: COMPLETED
-
Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)
NCT02049775 ·Status: UNKNOWN ·Phase: NA
-
Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
NCT00307827 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
NCT02229344 ·Status: COMPLETED
-
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease
NCT01505842 ·Status: UNKNOWN ·Phase: NA
-
Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis
NCT02569333 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Microscopic Colitis
NCT02699333 ·Status: COMPLETED
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
NCT04079335 ·Status: UNKNOWN
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
NCT01504048 ·Status: UNKNOWN ·Phase: NA
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Long-term Outcome of Patients With Acute Ulcerative Colitis After First Course of Intravenous Corticosteroids
NCT04564638 ·Status: COMPLETED
-
Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
NCT01456052 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
NCT06143163 ·Status: NOT_YET_RECRUITING
-
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
NCT02330458 ·Status: UNKNOWN
-
Study for the Treatment of Ulcerative Colitis With Adacolumn
NCT00102193 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.
NCT02600143 ·Status: COMPLETED
-
Exacerbating Factors in Inflammatory Bowel Disease
NCT01405105 ·Status: COMPLETED
-
Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis
NCT06449820 ·Status: COMPLETED
-
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.
NCT04272307 ·Status: UNKNOWN
-
Research Study in Patients With Severe Ulcerative Colitis
NCT00032305 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ocular Manifestations of Inflammatory Bowel Disease
NCT04771039 ·Status: COMPLETED
-
Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
NCT02770040 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED